Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019
Exciting clinical developments in the field of neuroendocrine carcinoma mean that patients are likely to receive a host of new treatment options within the next few years, according to a new report by healthcare intelligence company GlobalData.
View full press release